Reflections on Participation in a Trial on Hydroxychloroquine as Prevention for COVID-19 among Health Workers in Niger

In 2020, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), a rapidly emerging virus causing the coronavirus disease 2019 (COVID-19) pandemic, had no known effective prophylaxis and no widely available proven effective antiviral treatment. Hydroxychloroquine/Chloroquine was identified as...

Descripción completa

Detalles Bibliográficos
Autores principales: Kabore, Youssouf, Vatrinet, Renaud, Guindo, Ousmane, Moussa, Souleymane H., Schilling, William H. K., Grais, Rebecca F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The American Society of Tropical Medicine and Hygiene 2023
Materias:
Perspective
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10484280/
https://www.ncbi.nlm.nih.gov/pubmed/37580026
http://dx.doi.org/10.4269/ajtmh.22-0606

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10484280/
https://www.ncbi.nlm.nih.gov/pubmed/37580026
http://dx.doi.org/10.4269/ajtmh.22-0606

Ejemplares similares